— Know what they know.
Not Investment Advice

OMCL NASDAQ

Omnicell, Inc.
1W: -0.1% 1M: +19.4% 3M: +8.7% YTD: -3.1% 1Y: +52.0% 3Y: -37.7% 5Y: -66.8%
$44.41
+0.65 (+1.49%)
 
Weekly Expected Move ±11.6%
$33 $38 $43 $48 $53
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Buy · Power 68 · $2.0B mcap · 44M float · 1.31% daily turnover · Short 71% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.2B +6.5% ▲
5Y CAGR: +5.8%
Gross Profit
$503M +6.9% ▲
5Y CAGR: +4.0%
Operating Income
$5M +1431.2% ▲
5Y CAGR: -32.0%
Net Income
$2M -83.6% ▼
5Y CAGR: -42.3%
EPS (Diluted)
$0.04 -83.6% ▼
5Y CAGR: -43.1%
EBITDA
$96M +6.9% ▲
5Y CAGR: -2.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.1B$1.3B$1.1B$1.1B$1.2B
YoY Growth+26.9%+14.5%-11.5%-3.0%+6.5%
Cost of Revenue$577M$707M$647M$641M$681M
Gross Profit$555M$589M$500M$471M$503M
Gross Margin49.0%45.4%43.6%42.3%42.5%
R&D Expenses$76M$105M$93M$90M$89M
SG&A Expenses$389M$486M$426M$380M$410M
Operating Expenses$465M$591M$519M$471M$498M
Operating Income$90M-$2M-$19M$337K$5M
Operating Margin7.9%-0.2%-1.7%0.0%0.4%
Interest Expense$22M$130K$0$5M$6M
Income Before Tax$66M-$2M-$20M$26M$11M
Tax Expense-$12M-$8M$263K$13M$9M
Net Income$78M$6M-$20M$13M$2M
Net Margin6.9%0.4%-1.8%1.1%0.2%
EPS (Diluted)$1.62$0.12$-0.45$0.27$0.04
EBITDA$174M$97M$80M$90M$96M
Shares Outstanding48M46M45M46M46M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms